Templum to Offer Premier Private Market Investment Opportunities in Perplexity AI, OpenAI, and Colossal Biosciences to SoFi Members
MWN-AI** Summary
Templum, in partnership with SoFi, has announced an exclusive investment opportunity for accredited SoFi members, enabling access to prominent private companies—Colossal Biosciences, OpenAI, and Perplexity AI—through the Cosmos Fund. This limited-time offering will be available from March 5 to March 30, 2026, providing qualified investors a chance to invest in industry-leading firms that are reshaping their sectors.
Colossal Biosciences focuses on groundbreaking biotechnological advancements, including species preservation and climate science, recently achieving decacorn status backed by significant venture capital. OpenAI is at the forefront of artificial intelligence infrastructure and innovation, leveraging massive scale to enhance data utility, while Perplexity AI is revolutionizing digital search with a unique AI search engine that prioritizes reliable data, reaching approximately 22 million monthly active users.
Investors have the flexibility to allocate their capital across any of the three companies or choose to invest in all three offerings. This initiative marks Templum's commitment to broadening access to private market investments, targeting high-growth sectors such as Robotics, FinTech, and Defense Technology.
Templum's model integrates advanced technology for private market investing, providing robust solutions for wealth management firms and institutional brokers. As the landscape of private investments evolves, Templum aims to enhance operational efficiencies and open doors to more diverse investment opportunities.
This offering emphasizes Templum's role in modernizing the private investment ecosystem while making sophisticated financial products available to a wider base of investors. Interested parties can find more information on how to participate by visiting SoFi's dedicated investment webpage or reaching out to Templum’s investor support.
MWN-AI** Analysis
Templum’s recent announcement of offering private market investment opportunities in three groundbreaking companies—OpenAI, Perplexity AI, and Colossal Biosciences—through the Cosmos Fund should pique the interest of accredited investors. This limited-time investment window from March 5 to March 30, 2026, not only democratizes access to high-potential market leaders but also reflects a strategic move in a rapidly evolving landscape.
Investors should capitalize on this opportunity by diversifying their portfolios with these three cutting-edge firms. OpenAI stands at the forefront of artificial intelligence innovation, serving as a robust infrastructure for the next generation of AI applications. Its vast scale offers inherent advantages in data and ecosystem synchronization, establishing it as a key player. Similarly, Colossal Biosciences is disrupting biotech with its pioneering efforts in species preservation and climate science, having achieved decacorn status, which speaks volumes about its valuation and growth potential.
Moreover, Perplexity AI aims to redefine the search landscape with its innovative approach to data retrieval, recently growing its monthly active users significantly. This trend can offer investors a stake in a sector experiencing exponential growth, driven by the global shift towards AI-driven solutions.
Given the risks associated with private investments, potential investors should conduct thorough due diligence and carefully assess their risk tolerance. Additionally, taking advantage of the Cosmos Fund’s diversified investment opportunities—allowing allocations across all three companies—can mitigate risks while positioning portfolios for substantial returns in burgeoning industries.
As Templum moves to enhance private market access through advanced technology, investors should also look for subsequent opportunities across various sectors featured by the Cosmos Fund. This strategic approach could play a critical role in navigating the complexities of modern investment landscapes.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Limited-time offering provides investors access to highly sought-after private market leaders
NEW YORK, March 5, 2026 /PRNewswire/ -- Templum, a leading infrastructure provider for private markets and SoFi (NASDAQ: SOFI), the one-stop shop for digital financial services, today announced the launch of a limited-time private market investment window for accredited investors to access Colossal Biosciences, OpenAI, and/or Perplexity AI through the Cosmos Fund.
The three offerings will be available from March 5 through March 30, 2026, and represent the latest opportunities from the Cosmos Fund, which is designed to provide differentiated access to category-defining private companies for qualified investors.
OpenAI, Perplexity AI, and Colossal Biosciences – pioneers in their respective digital and biological markets – are redefining what's possible today across their sectors.
- Colossal Biosciences is pursuing a proprietary biotech platform with applications spanning de-extinction, species preservation, livestock optimization, climate science, and human therapeutics. The company's latest report states that it has achieved decacorn status, with backing from investors including?TWG Global?and other leading venture capital firms.
- OpenAI is striving to establish the operating system and infrastructure underpinning much of the next generation of AI innovation. Its enormous scale provides substantial data, distribution, and ecosystem advantages.
- Perplexity AI is focused on transforming how we digitally search with an AI search engine that uses referenceable data and facts to provide answers. The company's recent highlights include the launch of its Comet browser and the milestone of reaching approximately 22 million monthly active users (MAUs).
Accredited investors, once verified, have the option to allocate capital to any individual asset or across all three offerings. For additional details or to discuss participation, investors may visit www.sofi.com/invest/private-markets or contact Templum's investor support directly.
Looking forward, the Cosmos Fund will feature select investments from high-growth sectors, including Robotics, FinTech, Defense Technology, and Infrastructure, offered as limited, time-sensitive opportunities alongside top-tier investment products from industry-leading asset managers from Templum Markets throughout 2026.
About Templum
Templum is moving private markets investing forward by unifying the entire ecosystem. As a solution partner, Templum provides full investment lifecycle technologies, workflow solutions, and broker-dealer support configurable via white label, hybrid, or API deployments. The Company's offerings are purpose-built to enable private market strategies for wealthtech providers, RIAs, institutional brokers, banks, fintechs, online brokers, and asset managers. Templum is modernizing the technology backbone and opening access to a broader range of investment opportunities for a growing investor base. The Company's vision is to expand capital markets, making a giant step forward from the outmoded technology hindering investments today. Learn more at https://templuminc.com.
All securities offered by Templum Markets LLC, a wholly owned broker-dealer and Alternative Trading System (ATS) subsidiary of Templum, Inc. For more information, please visit https://templuminc.com. Templum does not have an affiliation with, formal relationship with, or endorsement from OpenAI, Perplexity AI, and Colossal Biosciences. None of the statements on this document should be attributed to OpenAI, Perplexity AI, Colossal Biosciences or its affiliates.
INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE |
SoFi Invest is a trade name used by SoFi Wealth LLC and SoFi Securities LLC offering investment products and services. Robo investing and advisory services are provided by SoFi Wealth LLC, an SEC-registered investment adviser. Brokerage and self-directed investing products offered through SoFi Securities LLC, Member FINRA/SIPC.
For disclosures on SoFi Invest platforms visit SoFi.com/legal. For a full listing of the fees associated with SoFi Invest please view our fee schedule
SOURCE Templum Inc.
FAQ**
How will SoFi Technologies Inc. SOFI ensure that its members fully understand the potential risks and benefits associated with investing in private market leaders like OpenAI, Colossal Biosciences, and Perplexity AI?
What specific criteria will SoFi Technologies Inc. SOFI use to determine the accredited investor status of participants in Templum's limited-time private market investment offerings?
Can you provide insights into the expected returns for investments in OpenAI, Colossal Biosciences, and Perplexity AI as part of Templum's Cosmos Fund offered to SoFi Technologies Inc. SOFI members?
How does Templum plan to support SoFi Technologies Inc. SOFI members in navigating the investment opportunities in high-growth sectors like AI and biotech through the Cosmos Fund?
**MWN-AI FAQ is based on asking OpenAI questions about SoFi Technologies Inc. (NASDAQ: SOFI).
NASDAQ: SOFI
SOFI Trading
-1.12% G/L:
$17.675 Last:
25,125,177 Volume:
$17.80 Open:
